Showing results (1501-1510 of 1,542) with videos related to
Sort By:
Pageof 155
EFSA Journal. European Food Safety Authority|July 7, 2020
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Batrachochytrium salamandrivorans (Bsal), Simon More, Anette Bøtner, et al.Stroke|October 27, 2022
Risk Factors for Perioperative Brain Lesions in Infants With Congenital Heart Disease: A European CollaborationAlexandra F Bonthrone, Raymond Stegeman, Maria Feldmann, et al.EFSA Journal. European Food Safety Authority|December 13, 2021
Assessment of the control measures of the category A diseases of Animal Health Law: Newcastle disease, Søren Saxmose Nielsen, Julio Alvarez, et al.EFSA Journal. European Food Safety Authority|July 31, 2025
Welfare of American mink, red and Arctic foxes, raccoon dog and chinchilla kept for fur production, Søren Saxmose Nielsen, Julio Álvarez, et al.EFSA Journal. European Food Safety Authority|December 22, 2025
Risk of infection of dairy cattle in the EU with highly pathogenic avian influenza virus affecting dairy cows in the United States of America (H5N1, Eurasian lineage goose/Guangdong clade 2.3.4.4b. genotype B3.13), Julio Alvarez, Anette Ella Boklund, et al.Science (New York, N.Y.)|November 11, 2020
Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humansBas B Oude Munnink, Reina S Sikkema, David F Nieuwenhuijse, et al.EMBO Molecular Medicine|June 14, 2022
Functional divergence of the two Elongator subcomplexes during neurodevelopmentMonika Gaik, Marija Kojic, Megan R Stegeman, et al.EFSA Journal. European Food Safety Authority|April 19, 2024
Vaccination of poultry against highly pathogenic avian influenza - Part 2. Surveillance and mitigation measures, , Søren Saxmose Nielsen, et al.EFSA Journal. European Food Safety Authority|October 12, 2023
Vaccination of poultry against highly pathogenic avian influenza - part 1. Available vaccines and vaccination strategies, Søren Saxmose Nielsen, Julio Alvarez, et al.The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.Pageof 155